1.Date of occurrence of the event:2018/12/18
2.Company name:China Chemical & Pharmaceutical Co., Ltd.
3.Relationship to the Company (please enter ”head office” or
  ”subsidiaries”):head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:
The operating revenue provided by the subsidiary was wrong and impact of
exchange differences
6.Information items/ statements to be corrected:
Announcement of the company's operating revenue from July to
October in 2018 and
the cumulative operating revenue announcement in November 2018
7.Amounts/ contents/ number of page to be corrected:
(1)July operating revenue came to $ 642,331,000 and
accumulated operating revenue came to $4,522,748,000
(2)August operating revenue came to $ 579,450,000 and
accumulated operating revenue came to $5,102,198,000
(3)September operating revenue came to $ 647,677,000 and
accumulated operating revenue came to $5,749,875,000
(4)October operating revenue came to $ 596,847,000 and
accumulated operating revenue came to $6,346,722,000
(5)November operating accumulated revenue came to $6,979,550,000
8.Amounts/ contents/ number of page after correction:
(1)July operating revenue came to $ 663,475,000 and
accumulated operating revenue came to $4,536,889,000
(2)August operating revenue came to $ 651,331,000 and
accumulated operating revenue came to $5,188,220,000
(3)September operating revenue came to $ 688,907,000 and
accumulated operating revenue came to $5,877,127,000
(4)October operating revenue came to $ 521,724,000 and
 accumulated operating revenue came to $6,398,851,000
(5)November operating accumulated revenue came to $7,031,679,000
9.Countermeasures:
Material information disclosure and amendment of revenue amount
10.Any other matters that need to be specified:
The company's operating revenue correction does not affect the profit amount